ABBOTT PARK, Ill., June 13, 2020 /PRNewswire/ -- Today, Abbott (NYSE: ABT) announced new late-breaking data demonstrating use of its FreeStyle Libre system, the world\'s leading3 continuous glucose monitoring (CGM) technology, is associated with significant reduction in hemoglobin A1c...
For more information, please visit
https://prnmedia.prnewswire.com:443/news[...]-insulin-or-not-301075390.html